Parkinson's disease is often associated with hallucinations and psychosis. Till now typical and atypical antipsychotics (Clozapine&Quetiapine) are being used to manage these symptoms. Recently US FDA has approved a new drug Pimavanserin for the treatment of hallucination and delusion associated with parkinson's disease psychosis in a dose of 34 mg.
Keywords
Hallucinations, Delusions, Psychosis, Parkinsonism, Pimavanserin.
User
Font Size
Information